Location History:
- New Taipei, TW (2018)
- Taipei, TW (2024)
Company Filing History:
4 out of 96 
1 out of 181 
Years Active: 2018-2025
Title: Cheng-Chou Yu: Innovator in Antibody Development
Introduction
Cheng-Chou Yu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 4 patents, his work has the potential to impact various medical treatments.
Latest Patents
Cheng-Chou Yu's latest patents include groundbreaking innovations such as anti-human PD-L1 antibodies and their uses. This patent describes an anti-PD-L1 antibody, or an antigen-binding fragment thereof, which comprises specific heavy and light chain variable regions. These antibodies are designed to be chimeric, humanized, composite, or human antibodies. Another notable patent is for humanized anti-human neurotensin receptor 1 antibodies and their uses. This invention outlines a method for treating and preventing diseases related to NTSR1 activity and provides a method or kit for detecting NTSR1 in a sample.
Career Highlights
Throughout his career, Cheng-Chou Yu has worked with esteemed organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Cheng-Chou Yu has collaborated with notable colleagues, including Shu-Ping Yeh and Chuan-Lung Hsu. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Cheng-Chou Yu is a distinguished inventor whose work in antibody development is paving the way for new therapeutic options. His contributions to biotechnology are significant and continue to influence the field.